Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective

Anemia is common in patients with cancer or with chronic kidney disease (CKD). Although the introduction of erythropoiesis-stimulating agents (ESAs) has transformed the management of anemia, their use has been complicated by a number of factors including frequent guideline updates, safety concerns a...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Matti Aapro, Pere Gascón, Kashyap Patel, George M. Rodgers, Selwyn Fung, Luiz H. Arantes, Jay Wish
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-01-01
Subjects:	anemia erythropoiesis-stimulating agents cancer kidney disease biosimilars
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2018.01498/full